GENMAB US, INC.

EPKINLY

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

GENMAB US, INC.

Epkinly HCPCS:

C9155

HCPCS Code Descriptor:

Injection, epcoritamab-bysp, 0.16 mg

Category:

C Code

Epkinly NDCs:

No actively aligned NDCs found

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Epkinly CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Epkinly:

EPKINLY is an Oncology drug manufactured by Genmab and administered via the subcutaneous route of administration. The C Code: C9155 is aligned to the drug EPKINLY.

ACCESS PRICING AND MORE BY REGISTERING

C9155 Added Date:

October 1, 2023

C9155 Effective Date:

October 1, 2023

C9155 Termination Date:

December 31, 2023

Epkinly billing and coding information can be found through Genmab Us, Inc. at the link below:
Epkinly patient assistance information can be found through MyNavCare at the URL: https://www.mynavcare.com/
EPKINLY prescribing information can be found at the link below:
Information regarding EPKINLY’s side effects can be found at MedlinePlus